glp-1 drug boom Eli Lilly has become the first pharmaceutical company ever to reach a $1 trillion market capitalization. A milestone driven largely by surging demand for its weight-loss and diabetes drugs, Mounjaro (for type Ease your GLP The GLP-1 boom created one

Among those on the highest dose, 54.6% achieved at least 10% weight loss, 36.0% achieved 15% or more, and 18.4% achieved 20% or more

The development of these agents underscores the continuous improvement of the pharmacokinetic and pharmacodynamic profiles of these peptide agents [ Table 1 ], expanding their applications beyond T2DM and obesity to encompass cardiovascular disease event reduction [ Table 2 ]

Smith Jan 12, 2026 Daddy Yankee: A Higher Note Nov 20, 2025 Gut Check: The Foods We Eat Nov 19, 2025 All Access With Linsey Davis: Stevie Van Zandt Nov 18, 2025 All Access with Linsey Davis: Andrew Cuomo Oct 30, 2025 All Access With Linsey Davis: Zohran Mamdani Oct 27, 2025 Springsteen: Deliver Me from Nowhere - A Conversation with the Cast Oct 21, 2025 All Access With Linsey Davis: Jeremy Allen White Oct 20, 2025 The Children of Gaza Oct 11, 2025 Glen Powell and Eli Manning: ABC News Live Prime with Linsey Davis Oct 06, 2025 The Playlist Presents: Dale Play

Currently, 30 drugs are in Phase III trials, 73 are in Phase II, and 82 are in Phase I

Bomba M, Ciavardelli D, Silvestri E, Canzoniero LM, Lattanzio R, Chiappini P, et al